Global Oncology/Cancer Drugs Market Insights and Forecast to 2026

Publisher Name :
Date: 20-Jul-2020
No. of pages: 114
Inquire Before Buying

Oncology/Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology/Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oncology/Cancer Drugs market is segmented into

- Antimetabolite

- Alkaloid drugs

- Hormone

- Targeted drug

- Platinum-based drugs

- Other

Segment by Application, the Oncology/Cancer Drugs market is segmented into

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory/Lung Cancer

- Other

Regional and Country-level Analysis

The Oncology/Cancer Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Oncology/Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Oncology/Cancer Drugs Market Share Analysis

Oncology/Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology/Cancer Drugs business, the date to enter into the Oncology/Cancer Drugs market, Oncology/Cancer Drugs product introduction, recent developments, etc.

The major vendors covered:

- Roche

- HENGRUI

- AstraZeneca

- QILU

- Sanofi

- HANSOH

- LUYE

- Novartis

- GuiZhou YiBai

- Lunan

- Eli Lilly and Company

Global Oncology/Cancer Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Oncology/Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Oncology/Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Type
1.4.2 Antimetabolite
1.4.3 Alkaloid drugs
1.4.4 Hormone
1.4.5 Targeted drug
1.4.6 Platinum-based drugs
1.4.7 Other
1.5 Market by Application
1.5.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Application
1.5.2 Blood Cancer
1.5.3 Breast Cancer
1.5.4 Gastrointestinal Cancer
1.5.5 Prostate Cancer
1.5.6 Respiratory/Lung Cancer
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oncology/Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Oncology/Cancer Drugs Revenue 2015-2026
2.1.2 Global Oncology/Cancer Drugs Sales 2015-2026
2.2 Global Oncology/Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oncology/Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oncology/Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oncology/Cancer Drugs Competitor Landscape by Players
3.1 Oncology/Cancer Drugs Sales by Manufacturers
3.1.1 Oncology/Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Oncology/Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Oncology/Cancer Drugs Revenue by Manufacturers
3.2.1 Oncology/Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Oncology/Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oncology/Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oncology/Cancer Drugs Revenue in 2019
3.2.5 Global Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oncology/Cancer Drugs Price by Manufacturers
3.4 Oncology/Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Oncology/Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology/Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oncology/Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Oncology/Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Oncology/Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Oncology/Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oncology/Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Oncology/Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oncology/Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oncology/Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Oncology/Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Oncology/Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Oncology/Cancer Drugs Price by Application (2015-2020)
5.2 Oncology/Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Oncology/Cancer Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oncology/Cancer Drugs by Country
6.1.1 North America Oncology/Cancer Drugs Sales by Country
6.1.2 North America Oncology/Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oncology/Cancer Drugs Market Facts & Figures by Type
6.3 North America Oncology/Cancer Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Oncology/Cancer Drugs by Country
7.1.1 Europe Oncology/Cancer Drugs Sales by Country
7.1.2 Europe Oncology/Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oncology/Cancer Drugs Market Facts & Figures by Type
7.3 Europe Oncology/Cancer Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oncology/Cancer Drugs by Region
8.1.1 Asia Pacific Oncology/Cancer Drugs Sales by Region
8.1.2 Asia Pacific Oncology/Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oncology/Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Oncology/Cancer Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oncology/Cancer Drugs by Country
9.1.1 Latin America Oncology/Cancer Drugs Sales by Country
9.1.2 Latin America Oncology/Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oncology/Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Oncology/Cancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oncology/Cancer Drugs by Country
10.1.1 Middle East and Africa Oncology/Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oncology/Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Oncology/Cancer Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Oncology/Cancer Drugs Products Offered
11.1.5 Roche Related Developments
11.2 HENGRUI
11.2.1 HENGRUI Corporation Information
11.2.2 HENGRUI Description and Business Overview
11.2.3 HENGRUI Sales, Revenue and Gross Margin (2015-2020)
11.2.4 HENGRUI Oncology/Cancer Drugs Products Offered
11.2.5 HENGRUI Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Description and Business Overview
11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Oncology/Cancer Drugs Products Offered
11.3.5 AstraZeneca Related Developments
11.4 QILU
11.4.1 QILU Corporation Information
11.4.2 QILU Description and Business Overview
11.4.3 QILU Sales, Revenue and Gross Margin (2015-2020)
11.4.4 QILU Oncology/Cancer Drugs Products Offered
11.4.5 QILU Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Oncology/Cancer Drugs Products Offered
11.5.5 Sanofi Related Developments
11.6 HANSOH
11.6.1 HANSOH Corporation Information
11.6.2 HANSOH Description and Business Overview
11.6.3 HANSOH Sales, Revenue and Gross Margin (2015-2020)
11.6.4 HANSOH Oncology/Cancer Drugs Products Offered
11.6.5 HANSOH Related Developments
11.7 LUYE
11.7.1 LUYE Corporation Information
11.7.2 LUYE Description and Business Overview
11.7.3 LUYE Sales, Revenue and Gross Margin (2015-2020)
11.7.4 LUYE Oncology/Cancer Drugs Products Offered
11.7.5 LUYE Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description and Business Overview
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Oncology/Cancer Drugs Products Offered
11.8.5 Novartis Related Developments
11.9 GuiZhou YiBai
11.9.1 GuiZhou YiBai Corporation Information
11.9.2 GuiZhou YiBai Description and Business Overview
11.9.3 GuiZhou YiBai Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GuiZhou YiBai Oncology/Cancer Drugs Products Offered
11.9.5 GuiZhou YiBai Related Developments
11.10 Lunan
11.10.1 Lunan Corporation Information
11.10.2 Lunan Description and Business Overview
11.10.3 Lunan Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lunan Oncology/Cancer Drugs Products Offered
11.10.5 Lunan Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Oncology/Cancer Drugs Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oncology/Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Oncology/Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Oncology/Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oncology/Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Oncology/Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oncology/Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Oncology/Cancer Drugs Market Segments
Table 2. Ranking of Global Top Oncology/Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oncology/Cancer Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antimetabolite
Table 5. Major Manufacturers of Alkaloid drugs
Table 6. Major Manufacturers of Hormone
Table 7. Major Manufacturers of Targeted drug
Table 8. Major Manufacturers of Platinum-based drugs
Table 9. Major Manufacturers of Other
Table 10. Global Oncology/Cancer Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Oncology/Cancer Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Oncology/Cancer Drugs Sales by Regions 2015-2020 (K MT)
Table 13. Global Oncology/Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Oncology/Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Oncology/Cancer Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global Oncology/Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Oncology/Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Oncology/Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology/Cancer Drugs as of 2019)
Table 19. Oncology/Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Oncology/Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Oncology/Cancer Drugs Price (2015-2020) (USD/MT)
Table 22. Oncology/Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oncology/Cancer Drugs Product Type
Table 24. Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 27. Global Oncology/Cancer Drugs Sales Share by Type (2015-2020)
Table 28. Global Oncology/Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Oncology/Cancer Drugs Revenue Share by Type (2015-2020)
Table 30. Oncology/Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 32. Global Oncology/Cancer Drugs Sales Share by Application (2015-2020)
Table 33. North America Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 34. North America Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 38. North America Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 40. North America Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 42. Europe Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 46. Europe Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 48. Europe Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Oncology/Cancer Drugs Sales by Region (2015-2020) (K MT)
Table 50. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Oncology/Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 54. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 56. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 58. Latin America Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 62. Latin America Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 64. Latin America Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 66. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 70. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 72. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 73. Roche Corporation Information
Table 74. Roche Description and Major Businesses
Table 75. Roche Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Roche Product
Table 77. Roche Recent Development
Table 78. HENGRUI Corporation Information
Table 79. HENGRUI Description and Major Businesses
Table 80. HENGRUI Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. HENGRUI Product
Table 82. HENGRUI Recent Development
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Major Businesses
Table 85. AstraZeneca Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. AstraZeneca Product
Table 87. AstraZeneca Recent Development
Table 88. QILU Corporation Information
Table 89. QILU Description and Major Businesses
Table 90. QILU Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. QILU Product
Table 92. QILU Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Major Businesses
Table 95. Sanofi Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. HANSOH Corporation Information
Table 99. HANSOH Description and Major Businesses
Table 100. HANSOH Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. HANSOH Product
Table 102. HANSOH Recent Development
Table 103. LUYE Corporation Information
Table 104. LUYE Description and Major Businesses
Table 105. LUYE Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. LUYE Product
Table 107. LUYE Recent Development
Table 108. Novartis Corporation Information
Table 109. Novartis Description and Major Businesses
Table 110. Novartis Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Novartis Product
Table 112. Novartis Recent Development
Table 113. GuiZhou YiBai Corporation Information
Table 114. GuiZhou YiBai Description and Major Businesses
Table 115. GuiZhou YiBai Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. GuiZhou YiBai Product
Table 117. GuiZhou YiBai Recent Development
Table 118. Lunan Corporation Information
Table 119. Lunan Description and Major Businesses
Table 120. Lunan Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Lunan Product
Table 122. Lunan Recent Development
Table 123. Eli Lilly and Company Corporation Information
Table 124. Eli Lilly and Company Description and Major Businesses
Table 125. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. Eli Lilly and Company Product
Table 127. Eli Lilly and Company Recent Development
Table 128. Global Oncology/Cancer Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 129. Global Oncology/Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Oncology/Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 133. North America: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 135. Europe: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Oncology/Cancer Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 137. Asia Pacific: Oncology/Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 139. Latin America: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 141. Middle East and Africa: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Oncology/Cancer Drugs Players
Table 146. Oncology/Cancer Drugs Customers List
Table 147. Oncology/Cancer Drugs Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology/Cancer Drugs Product Picture
Figure 2. Global Oncology/Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Antimetabolite Product Picture
Figure 4. Alkaloid drugs Product Picture
Figure 5. Hormone Product Picture
Figure 6. Targeted drug Product Picture
Figure 7. Platinum-based drugs Product Picture
Figure 8. Other Product Picture
Figure 9. Global Oncology/Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Other
Figure 16. Oncology/Cancer Drugs Report Years Considered
Figure 17. Global Oncology/Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Oncology/Cancer Drugs Sales 2015-2026 (K MT)
Figure 19. Global Oncology/Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Oncology/Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Oncology/Cancer Drugs Sales Market Share by Region in 2019
Figure 22. Global Oncology/Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Oncology/Cancer Drugs Revenue Market Share by Region in 2019
Figure 24. Global Oncology/Cancer Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Oncology/Cancer Drugs Revenue in 2019
Figure 26. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Oncology/Cancer Drugs Sales Market Share by Type in 2019
Figure 29. Global Oncology/Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Oncology/Cancer Drugs Revenue Market Share by Type in 2019
Figure 31. Global Oncology/Cancer Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Oncology/Cancer Drugs Sales Market Share by Application in 2019
Figure 34. Global Oncology/Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2019
Figure 36. North America Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 39. North America Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Oncology/Cancer Drugs Market Share by Type in 2019
Figure 45. North America Oncology/Cancer Drugs Market Share by Application in 2019
Figure 46. Europe Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 49. Europe Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Oncology/Cancer Drugs Market Share by Type in 2019
Figure 61. Europe Oncology/Cancer Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Region in 2019
Figure 66. China Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Oncology/Cancer Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Oncology/Cancer Drugs Market Share by Application in 2019
Figure 90. Latin America Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Oncology/Cancer Drugs Market Share by Type in 2019
Figure 101. Latin America Oncology/Cancer Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Oncology/Cancer Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Oncology/Cancer Drugs Market Share by Application in 2019
Figure 114. North America Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
  • Global Prostate Cancer Drugs Market Research Report 2021
    Published: 21-Jan-2021        Price: US 2900 Onwards        Pages: 132
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Hormonal Therapy - Chemotherapy - Immunotherapy - Targeted Therapy Segment by Applica......
  • Global Cyclophosphamide Market Growth 2021-2026
    Published: 20-Jan-2021        Price: US 3660 Onwards        Pages: 130
    According to this latest study, the 2020 growth of Cyclophosphamide will have significant change from previous year. By the most conservative estimates of global Cyclophosphamide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 616.5 million in 2019. Over the next five years the Cyclophosphamide market will register a 2.2% CAGR in terms of revenue, the global market size will reach US$ 672.8 million by 2025. This report presen......
  • Global Breast Cancer Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 19-Jan-2021        Price: US 3500 Onwards        Pages: 113
    Breast cancer is a disease in which cells in the breast grow out of control. There are different kinds of breast cancer. The kind of breast cancer depends on which cells in the breast turn into cancer. Based on the Breast Cancer market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive......
  • Global Polymer Drug Conjugates Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 19-Jan-2021        Price: US 3500 Onwards        Pages: 104
    Based on the Polymer Drug Conjugates market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in ......
  • Global Hydroxycarbamide Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Capsule - Tablet Segment by Application - Sickle Cell Disease - Cancer - Other......
  • Global Cancer Treatment Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 133
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chemotherapy - Targeted Therapy - Immunotherapy - Hormonal Therapy (Biologic Therapy) - Other......
  • Global DNA Repair Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - PARP Inhibitors - Other Segment by Application - Oncological - Stroke ......
  • Global Docetaxel Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 20 mg/ml - 40 mg/ml - 60 mg/ml Segment by Application - Breast Cancer - Prosta......
  • Global Multiple Myeloma Drugs Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chemotherapy - Corticosteroids - Immunomodulators - Monoclonal Antibodies - Histone Deacetyla......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs